iSpecimen amends bylaws to lower quorum requirement for shareholder meetings

Published 10/07/2025, 21:58
iSpecimen amends bylaws to lower quorum requirement for shareholder meetings

iSpecimen Inc. (NASDAQ:ISPC), currently trading at $1.09 with a market capitalization of $2.71 million, amended its bylaws on Wednesday to reduce the quorum requirement for shareholder meetings. According to a statement filed with the Securities and Exchange Commission, the company has lowered the threshold for a quorum from a majority of the voting power of outstanding shares entitled to vote at a meeting to 34% of such voting power. The move comes as the company’s stock has declined over 81% in the past year.

The amendment to the Second Amended and Restated Bylaws was approved on July 9, 2025. A copy of the updated bylaws was filed as an exhibit with the SEC. InvestingPro analysis indicates the company faces financial challenges, with a WEAK overall financial health score and rapidly diminishing cash reserves.

iSpecimen is incorporated in Delaware and its common stock is listed on the Nasdaq Stock Market LLC. The company’s principal executive offices are located in Woburn, Massachusetts. The filing was signed by Chief Executive Officer Robert Bradley Lim.

This article is based on a press release statement and information disclosed in a recent SEC filing.

In other recent news, iSpecimen Inc. announced changes to its board of directors. Last week, Richard J. Paolone and John L. Brooks III resigned from the board, with the company clarifying that their departures were not due to disagreements with management or board policies. Following these resignations, Anthony Lau was appointed as a new director. Mr. Lau will also serve as chair of the audit committee and has been named to the compensation and nominating and corporate governance committees. He brings experience from his roles at Remington Resources, Inc., where he is the CEO and CFO. The board has confirmed that Mr. Lau has no family relationships with any current directors or executive officers at iSpecimen. Additionally, the board has determined that Mr. Lau, along with Mr. Dhaliwal and Ms. Yang, qualify as independent directors. The board continues to assess committee compositions and director succession planning.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.